Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
BMC Health Services Research
|
May 3, 2024
A survey on the implementation of clinical medication reviews in community pharmacies within a multidisciplinary setting
S Hogervorst, M C Adriaanse, M Vervloet, et al.
Cancer
|
October 1, 1996
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group
G Emons, O Ortmann, H M Teichert, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 6, 2000
In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene
A M Teichert, T L Miller, S C Tai, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2009
Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period
M Teichert, R H N van Schaik, A Hofman, et al.
Inorganic Chemistry
|
February 24, 2001
Experimental and theoretical studies of the d8-d10 interaction between Pd(II) and Au(I): bis(chloro[(phenylthiomethyl)diphenylphosphine]gold(I))- dichloropalladium(II) and related systems
O Crespo, A Laguna, E J Fernández, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 26, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study
M Teichert, L E Visser, R H N van Schaik, et al.
Biology of Sex Differences
|
May 4, 2021
Sex differences associated with adverse drug reactions resulting in hospital admissions
L C Hendriksen, P D van der Linden, A L M Lagro-Janssen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2012
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
T I Verhoef, W K Redekop, M M Buikema, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
BMC Health Services Research
|
May 3, 2024
A survey on the implementation of clinical medication reviews in community pharmacies within a multidisciplinary setting
S Hogervorst, M C Adriaanse, M Vervloet, et al.
Cancer
|
October 1, 1996
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group
G Emons, O Ortmann, H M Teichert, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 6, 2000
In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene
A M Teichert, T L Miller, S C Tai, et al.
Clinical Pharmacology and Therapeutics
|
February 20, 2009
Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period
M Teichert, R H N van Schaik, A Hofman, et al.
Inorganic Chemistry
|
February 24, 2001
Experimental and theoretical studies of the d8-d10 interaction between Pd(II) and Au(I): bis(chloro[(phenylthiomethyl)diphenylphosphine]gold(I))- dichloropalladium(II) and related systems
O Crespo, A Laguna, E J Fernández, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 26, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study
M Teichert, L E Visser, R H N van Schaik, et al.
Biology of Sex Differences
|
May 4, 2021
Sex differences associated with adverse drug reactions resulting in hospital admissions
L C Hendriksen, P D van der Linden, A L M Lagro-Janssen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2012
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
T I Verhoef, W K Redekop, M M Buikema, et al.
Clinical Pharmacology and Therapeutics
|
November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis
E Danese, M Montagnana, J A Johnson, et al.
Page
of 3